Journal article icon

Journal article

Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.

Abstract:

It has been suggested that antidepressants that increase noradrenergic transmission should be better than serotonergic antidepressants at treating fatigue in depression. We conducted a secondary analysis of an RCT in which patients with depression were randomly assigned to reboxetine (a noradrenaline reuptake inhibitor [NARI]) or citalopram (a selective serotonin reuptake inhibitor [SSRI]). We investigated the difference between citalopram and reboxetine in treating the symptom of fatigue in ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1177/0269881111431753

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Psychiatry
Potokar, J More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Psychiatry
Expand authors...
Journal:
Journal of psychopharmacology (Oxford, England)
Volume:
26
Issue:
5
Pages:
663-669
Publication date:
2012-05-05
DOI:
EISSN:
1461-7285
ISSN:
0269-8811
URN:
uuid:81159782-92ee-4a24-a9d6-161912c9e6eb
Source identifiers:
340230
Local pid:
pubs:340230

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP